Pacific Cancer Medical Center, Inc. — Anaheim, California

Public research footprint of Pacific Cancer Medical Center, Inc., compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-small Cell Lung Cancer · KRAS p, G12c Mutated /Advanced Metastatic NSCLC · Metastatic Castration Resistant Prostate Cancer (mCRPC)

Recently updated registry entries

NCT03425643 — Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as… (Active Not Recruiting)
NCT03460977 — A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant… (Recruiting)
NCT04303780 — Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Pacific Cancer Medical Center, Inc.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.